Next Generation Approach

The increasing fear of drug-resistant superbugs is leading to a growing push for the next generation of antibiotics. The development of new antibiotics is crucial to controlling current and future infectious diseases caused by antibiotic-resistant bacteria. The discovery of a new antibiotic called teixobactin was announced by international team of researchers in 2017. The researchers now plan on studying the bacteria and decide what tools might be able to control its behavior to release its full antibiotic potential. An expected 5– 10% of all hospitalizations are perplex by a nosocomial disease with an expected cost of $4.5– 5.7 billion every year in the USA alone. More varieties of biological solution are yet to be discovered in this field.

 

  • Bacterial Biofilms
  • Oral Antibiotic Therapy
  • Combination Therapy
  • Empiric Antibiotic Therapy
  • Molecular Epidemiology

Related Conference of Next Generation Approach

February 07-08, 2022

International Conference on Vaccine Research

Paris, France
March 21-22, 2022

37th International Conference on Immunology

Brussels, Belgium
March 21-22, 2022

15th Global Summit on Immunology and Cell Biology

Tokyo, Japan
March 30-31, 2022

2nd European Congress on Virology and Immunology

Paris, France
April 11-12, 2022

3rd International Conference on Immunology & Immunotherapies

Singapore City, Singapore
April 11-12, 2022

17th International Conference on Allergy and Clinical Immunology

Singapore City, Singapore
May 02-03, 2022

16th International Conference on European Immunology

Zurich, Switzerland
May 18-19, 2022

4th World Conference on Vaccine and Immunology

Osaka, Japan
August 03-04, 2022

Rheumatology 2022

Zurich, Switzerland
August 22-23, 2022

4th World Congress on Vaccine and Immunology

Toronto, Canada
September 16-17, 2022

International Conference on Immunology Research

New York, USA

Next Generation Approach Conference Speakers

Recommended Sessions

Related Journals

Are you interested in